During the protumor inflammatory phase of lung cancer, TGF-α stimulation can increase MHC-II expression on alveolar type II cells, triggering Treg expansion and facilitating the development of inflammation-driven lung adenocarcinoma (41). Here, TGFA is linked to lung carcinoma.